https://www.selleckchem.com/pr....oducts/Rosuvastatin-
dence-based guidelines for CINV management leading to the practice of personalized and precise treatment recommendation, better life quality of patient, and reduced healthcare cost. The approach presented in this article can be applied to any other clinical predictions.Atrial Fibrillation (AF) at an early stage has a short duration and is sometimes asymptomatic, making it difficult to detect. Although the use of mobile sensing devices has provided the possibility of real-time cardiac detection, it is highly suscept
Like
Comment
Share
